CGRP 和降钙素在其不同受体的水平上相互交叉反应。α-CGRP (8-37) 已被描述为 CGRP 受体的选择性拮抗剂，但不是降钙素受体的选择性拮抗剂。因此，该片段似乎是受体表征研究的宝贵工具。
编号：159755
CAS号：119911-68-1
单字母：H2N-VTHRLAGLLSRSGGVVKNNFVPTNVGSKAF-CONH2
CGRP 和降钙素在其不同受体的水平上相互交叉反应。α-CGRP (8-37) 已被描述为 CGRP 受体的选择性拮抗剂，但不是降钙素受体的选择性拮抗剂。因此，该片段似乎是受体表征研究的宝贵工具。
CGRP and calcitonin cross-react with each other at the levels of their distinct receptors. α-CGRP (8-37) has been described as a selective antagonist for CGRP receptors but not for calcitonin receptors. This fragment thus appears to be a valuable tool for receptor characterization studies.
| DOI | 名称 | |
|---|---|---|
| 10.1074/jbc.M107384200 | Functional expression of heteromeric calcitonin gene-related peptide and adrenomedullin receptors in yeast | 下载 |
| 10.1016/s0301-472x(02)00772-5 | Regulation and function of the CGRP receptor complex in human granulopoiesis | 下载 |
| 10.1053/gast.2002.34176 | Amylin, released from the gastric fundus, stimulates somatostatin and thus inhibits histamine and acid secretion in mice | 下载 |
| 10.1167/iovs.02-1312 | Adrenomedullin-induced endothelium-dependent relaxation in porcine ciliary arteries | 下载 |
| 10.1124/mol.104.008615 | Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes | 下载 |
| 10.1016/j.bcp.2005.01.008 | Cys2,7EtalphaCGRP is a potent agonist for CGRP1 receptors in SK-N-MC cells | 下载 |
| 10.1038/sj.bjp.0706232 | Increased alphaCGRP potency and CGRP-receptor antagonist affinity in isolated hypoxic porcine intramyocardial arteries | 下载 |
| 10.1016/j.peptides.2005.02.015 | Potential role of the neuropeptide CGRP in the induction of differentiation of rat hepatic portal vein wall | 下载 |
| 10.1210/en.2007-1735 | Receptor activity-modifying proteins differentially modulate the G protein-coupling efficiency of amylin receptors | 下载 |
| 10.1016/j.peptides.2008.12.011 | Effects of adrenomedullin on systolic and diastolic myocardial function | 下载 |
| 10.1002/ana.21897 | Triptan-induced latent sensitization: a possible basis for medication overuse headache | 下载 |
| 10.1371/journal.pone.0010917 | Stimuli of sensory-motor nerves terminate arterial contractile effects of endothelin-1 by CGRP and dissociation of ET-1/ET(A)-receptor complexes | 下载 |
| 10.1016/j.bbi.2011.02.007 | Calcitonin gene-related peptide inhibits chemokine production by human dermal microvascular endothelial cells | 下载 |
| 10.1111/j.1476-5381.2011.01540.x | Intermedin (adrenomedullin2) stabilizes the endothelial barrier and antagonizes thrombin-induced barrier failure in endothelial cell monolayers | 下载 |
| 10.1038/jid.2013.47 | Adrenomedullin haploinsufficiency predisposes to secondary lymphedema | 下载 |
| 10.1152/ajpendo.1989.256.2.E331 | Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37) | 下载 |
| 10.1002/prp2.52 | Investigating the potential role of TRPA1 in locomotion and cardiovascular control during hypertension | 下载 |
| 10.1016/0196-9781(94)00195-c | Adrenomedullin and calcitonin gene-related peptide interact with the same receptor in cultured human neuroblastoma SK-N-MC cells | 下载 |
| 10.1023/a:1006962221332 | Calcitonin gene-related peptide receptor independently stimulates 3',5'-cyclic adenosine monophosphate and Ca2+ signaling pathways | 下载 |
| 10.1016/j.neuroscience.2008.02.054 | Identification of capsaicin-sensitive rectal mechanoreceptors activated by rectal distension in mice | 下载 |
多肽H2N-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2的合成步骤：
1、合成MBHA树脂：取若干克的MBHA树脂（如初始取代度为0.5mmol/g）和1倍树脂摩尔量的Fmoc-Linker-OH加入到反应器中，加入DMF，搅拌使氨基酸完全溶解。再加入树脂2倍量的DIEPA，搅拌混合均匀。再加入树脂0.95倍量的HBTU，搅拌混合均匀。反应3-4小时后，用DMF洗涤3次。用2倍树脂体积的10%乙酸酐/DMF 进行封端30分钟。然后再用DMF洗涤3次，甲醇洗涤2次，DCM洗涤2次，再用甲醇洗涤2次。真空干燥12小时以上，得到干燥的树脂{Fmoc-Linker-MHBA Resin}，测定取代度。这里测得取代度为 0.3mmol/g。结构如下图：
2、脱Fmoc：取1.48g的上述树脂，用DCM或DMF溶胀20分钟。用DMF洗涤2遍。加3倍树脂体积的20%Pip/DMF溶液，鼓氮气30分钟，然后2倍树脂体积的DMF 洗涤5次。得到 H2N-Linker-MBHA Resin 。（此步骤脱除Fmoc基团，茚三酮检测为蓝色，Pip为哌啶）。结构图如下：
3、缩合：取1.33mmol Fmoc-Phe-OH 氨基酸，加入到上述树脂里，加适当DMF溶解氨基酸，再依次加入2.66mmol DIPEA，1.27mmol HBTU。反应30分钟后，取小样洗涤，茚三酮检测为无色。用2倍树脂体积的DMF 洗涤3次树脂。（洗涤树脂，去掉残留溶剂，为下一步反应做准备）。得到Fmoc-Phe-Linker-MBHA Resin。氨基酸：DIPEA：HBTU：树脂=3：6：2.85：1（摩尔比）。结构图如下：
4、依次循环步骤二、步骤三，依次得到
H2N-Phe-Linker-MBHA Resin
Fmoc-Ala-Phe-Linker-MBHA Resin
H2N-Ala-Phe-Linker-MBHA Resin
Fmoc-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
H2N-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
Fmoc-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
H2N-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
Fmoc-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
H2N-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
Fmoc-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
H2N-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
Fmoc-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
H2N-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
Fmoc-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
H2N-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
Fmoc-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
H2N-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
Fmoc-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
H2N-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
Fmoc-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
H2N-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
Fmoc-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
H2N-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
Fmoc-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
H2N-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
Fmoc-Lys(Boc)-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
H2N-Lys(Boc)-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
Fmoc-Val-Lys(Boc)-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
H2N-Val-Lys(Boc)-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
Fmoc-Val-Val-Lys(Boc)-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
H2N-Val-Val-Lys(Boc)-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
Fmoc-Gly-Val-Val-Lys(Boc)-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
H2N-Gly-Val-Val-Lys(Boc)-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
Fmoc-Gly-Gly-Val-Val-Lys(Boc)-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
H2N-Gly-Gly-Val-Val-Lys(Boc)-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
Fmoc-Ser(tBu)-Gly-Gly-Val-Val-Lys(Boc)-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
H2N-Ser(tBu)-Gly-Gly-Val-Val-Lys(Boc)-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
Fmoc-Arg(Pbf)-Ser(tBu)-Gly-Gly-Val-Val-Lys(Boc)-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
H2N-Arg(Pbf)-Ser(tBu)-Gly-Gly-Val-Val-Lys(Boc)-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
Fmoc-Ser(tBu)-Arg(Pbf)-Ser(tBu)-Gly-Gly-Val-Val-Lys(Boc)-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
H2N-Ser(tBu)-Arg(Pbf)-Ser(tBu)-Gly-Gly-Val-Val-Lys(Boc)-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
Fmoc-Leu-Ser(tBu)-Arg(Pbf)-Ser(tBu)-Gly-Gly-Val-Val-Lys(Boc)-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
H2N-Leu-Ser(tBu)-Arg(Pbf)-Ser(tBu)-Gly-Gly-Val-Val-Lys(Boc)-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
Fmoc-Leu-Leu-Ser(tBu)-Arg(Pbf)-Ser(tBu)-Gly-Gly-Val-Val-Lys(Boc)-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
H2N-Leu-Leu-Ser(tBu)-Arg(Pbf)-Ser(tBu)-Gly-Gly-Val-Val-Lys(Boc)-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
Fmoc-Gly-Leu-Leu-Ser(tBu)-Arg(Pbf)-Ser(tBu)-Gly-Gly-Val-Val-Lys(Boc)-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
H2N-Gly-Leu-Leu-Ser(tBu)-Arg(Pbf)-Ser(tBu)-Gly-Gly-Val-Val-Lys(Boc)-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
Fmoc-Ala-Gly-Leu-Leu-Ser(tBu)-Arg(Pbf)-Ser(tBu)-Gly-Gly-Val-Val-Lys(Boc)-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
H2N-Ala-Gly-Leu-Leu-Ser(tBu)-Arg(Pbf)-Ser(tBu)-Gly-Gly-Val-Val-Lys(Boc)-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
Fmoc-Leu-Ala-Gly-Leu-Leu-Ser(tBu)-Arg(Pbf)-Ser(tBu)-Gly-Gly-Val-Val-Lys(Boc)-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
H2N-Leu-Ala-Gly-Leu-Leu-Ser(tBu)-Arg(Pbf)-Ser(tBu)-Gly-Gly-Val-Val-Lys(Boc)-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
Fmoc-Arg(Pbf)-Leu-Ala-Gly-Leu-Leu-Ser(tBu)-Arg(Pbf)-Ser(tBu)-Gly-Gly-Val-Val-Lys(Boc)-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
H2N-Arg(Pbf)-Leu-Ala-Gly-Leu-Leu-Ser(tBu)-Arg(Pbf)-Ser(tBu)-Gly-Gly-Val-Val-Lys(Boc)-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
Fmoc-His(Trt)-Arg(Pbf)-Leu-Ala-Gly-Leu-Leu-Ser(tBu)-Arg(Pbf)-Ser(tBu)-Gly-Gly-Val-Val-Lys(Boc)-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
H2N-His(Trt)-Arg(Pbf)-Leu-Ala-Gly-Leu-Leu-Ser(tBu)-Arg(Pbf)-Ser(tBu)-Gly-Gly-Val-Val-Lys(Boc)-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
Fmoc-Thr(tBu)-His(Trt)-Arg(Pbf)-Leu-Ala-Gly-Leu-Leu-Ser(tBu)-Arg(Pbf)-Ser(tBu)-Gly-Gly-Val-Val-Lys(Boc)-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
H2N-Thr(tBu)-His(Trt)-Arg(Pbf)-Leu-Ala-Gly-Leu-Leu-Ser(tBu)-Arg(Pbf)-Ser(tBu)-Gly-Gly-Val-Val-Lys(Boc)-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
Fmoc-Val-Thr(tBu)-His(Trt)-Arg(Pbf)-Leu-Ala-Gly-Leu-Leu-Ser(tBu)-Arg(Pbf)-Ser(tBu)-Gly-Gly-Val-Val-Lys(Boc)-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin
以上中间结构，均可在专肽生物多肽计算器-多肽结构计算器中，一键画出。
最后再经过步骤二得到 H2N-Val-Thr(tBu)-His(Trt)-Arg(Pbf)-Leu-Ala-Gly-Leu-Leu-Ser(tBu)-Arg(Pbf)-Ser(tBu)-Gly-Gly-Val-Val-Lys(Boc)-Asn(Trt)-Asn(Trt)-Phe-Val-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Lys(Boc)-Ala-Phe-Linker-MBHA Resin，结构如下：
5、切割：6倍树脂体积的切割液（或每1g树脂加8ml左右的切割液），摇床摇晃 2小时，过滤掉树脂，用冰无水乙醚沉淀滤液，并用冰无水乙醚洗涤沉淀物3次，最后将沉淀物放真空干燥釜中，常温干燥24小试，得到粗品H2N-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2。结构图见产品结构图。
切割液选择：1）TFA：H2O=95%：5%
2）TFA：H2O：TIS=95%：2.5%：2.5%
3）三氟乙酸：茴香硫醚：1，2-乙二硫醇：苯酚：水=87.5%：5%：2.5%：2.5%：2.5%
（前两种适合没有容易氧化的氨基酸，例如Trp、Cys、Met。第三种适合几乎所有的序列。）
6、纯化冻干：使用液相色谱纯化，收集目标峰液体，进行冻干，获得蓬松的粉末状固体多肽。不过这时要取小样复测下纯度 是否目标纯度。
7、最后总结：
杭州专肽生物技术有限公司（ALLPEPTIDE https://www.allpeptide.com）主营定制多肽合成业务，提供各类长肽，短肽，环肽，提供各类修饰肽，如：荧光标记修饰（CY3、CY5、CY5.5、CY7、FAM、FITC、Rhodamine B、TAMRA等），功能基团修饰肽（叠氮、炔基、DBCO、DOTA、NOTA等），同位素标记肽（N15、C13），订书肽（Stapled Peptide）,脂肪酸修饰肽（Pal、Myr、Ste），磷酸化修饰肽（P-Ser、P-Thr、P-Tyr），环肽（酰胺键环肽、一对或者多对二硫键环），生物素标记肽，PEG修饰肽，甲基化修饰肽等。
以上所有内容，为专肽生物原创内容，请勿发布到其他网站上。
